Effect of certain tablet formulation factors on dissolution of aspirin tablets
Ayub, S.; Ali, S.A.
Jpma. Journal of the Pakistan Medical Association 29(5): 91-92
1979
ISSN/ISBN: 0030-9982 PMID: 109641 Document Number: 140924
Document emailed within 1 workday
Related Documents
Hoblitzell, J.R.; Thakker, K.D.; Rhodes, C.T. 1985: Effects of moderate stress storage conditions on the dissolution profile of enteric-coated aspirin tablets Pharmaceutica Acta Helvetiae 60(1): 28-32Asker, A.F.; Saied, K.M.; Abdel-Khalek, M.M. 1975: Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 7: Formulation and evaluation of ascorbic acid and phenobarbitone tablets Die Pharmazie 30(7): 466-470
Khalil, S.A.; Ali, L.M. 1972: Some formulation factors affecting disintegration and dissolution of chloramphenicol capsules Acta Pharmaceutica Suecica 9(6): 563-572
Lerk, C.F.; Bolhuis, G.K.; Smallenbroek, A.J.; Zuurman, K. 1982: Interaction of tablet disintegrants and magnesium stearate during mixing. II. Effect on dissolution rate Pharmaceutica Acta Helvetiae 57(10-11): 282-286
Ammar, H.O.; Khalil, R.M. 1996: Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. part 6: rifampicin Die Pharmazie 51(3): 165-168
Boymond, C.; Gissinger, D.; Stamm, A. 1982: Effect of various disintegrating agents on the speed of dissolution of phenacetin tablets Pharmaceutica Acta Helvetiae 57(5-6): 131-135
Borg, K.O.; Jeppsson, J.; Sjögren, J. 1974: Influence of the dissolution rate of lithium tablets on side-effect Acta Pharmaceutica Suecica 11(2): 133-140
Nyqvist, H.; Lundgren, P.; Nyström, C.; Wadsten, T. 1978: Studies on the physical properties of tablets and tablet excipients. I. Adsorption of drugs to cellulose used in tablets Acta Pharmaceutica Suecica 15(2): 150-159
Hollenbach, K.; Pintye-Hódi, K.; Kedvessy, G. 1980: On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital a (modifications i and IIi and their release from tablets Die Pharmazie 35(1): 32-35
Zgoda, M.M.; Woskowicz, M.; Nachajski, M.; Haeusler, O.; Iwanczyk, M. 2004: The effect of xylitol on the stability and morphological parameters of tablets with sorbitol made by direct tabletting of formulation components Die Pharmazie 59(8): 651-653
Selmeczi, B.; Kedvessy, G.; Nagy, G.; Pintyéné Hódi, K.; Tencova, A.; Kiszeleva, G. 1981: Influence of the technological procedure and additives on the dissolution rate and absorption of active ingredients. I. Physical properties of acetylsalicylic acid tablets and of the dissolution rate of the active ingredient Acta Pharmaceutica Hungarica 51(5): 222-227
Induri, M.; Mantripragada, B.R.; Yejella, R.P.; Kunda, P.R.; Nannapaneni, D.T.; Boddu, R. 2012: Dissolution studies and quantification of meloxicam in tablet dosage form by spectrophotometry Pakistan Journal of Pharmaceutical Sciences 25(1): 283-287
Ayres, J.W. 1980: Lot-to-lot variation in dissolution of tolbutamide tablets American Journal of Hospital Pharmacy 37(10): 1329-1332
Salib, N.N.; El-Gamal, S.A. 1976: Application of some polymers in the physiocochemical design of tablet formulation Die Pharmazie 31(10): 718-721
Obuekwe, I.F.; Eichie, F. 2006: The presence of microorganisms in some common excipients used in tablet formulation Acta Poloniae Pharmaceutica 63(2): 121-125
Celebi, N.; Kişlal, O. 1995: Development and evaluation of a buccoadhesive propranolol tablet formulation Die Pharmazie 50(7): 470-472
Deák, D.; Pintye-Hódi, K.; Szabó-Révész, P.; Kása, P.; Erós, I.; Muskó, Z. 2000: Mathematical evaluation of the dissolution of metronidazole from tablets Die Pharmazie 55(5): 394-395
Eyjolfsson, R. 2003: Ranitidine tablets: an improved dissolution method Die Pharmazie 58(3): 220
Newth, C.J.; Isles, A.F. 1984: Assessment of a sustained release capsule and a tablet formulation of theophylline British Journal of Clinical Practice. Suppl 35: 53-54
Herrmann, R.; Kleinbloesem, C.H. 1994: Bioequivalence of a new tablet formulation of sotalol hydrochloride in comparison to a standard preparations Arzneimittel-Forschung 44(5): 589-592